A vaccine can be scientifically perfect and still fail to reach the person who needs it. Sometimes the problem is a refrigerator. We are building a company to design proteins that keep medicines working without one.
Our vision No vaccine lost to a broken cold chain.
Early-stage startup · backed by 1517 Fund, a Silicon Valley venture fund · looking for a wet lab partner
Wyrd Bio is an early-stage company backed by a Silicon Valley venture fund. Our goal is to turn a promising idea into a technology that helps medicines reach the people who need them. The first job is to show it works.
Founder of Wyrd Bio, a high-school student working in biotech and computational biology. The company was inspired by her fellowship at Non Trivial, where she worked on quantifying dengue tests.
Wyrd Bio is backed by 1517 Fund, a Silicon Valley venture fund that backs young builders working on hard problems.
Many vaccines and biologic medicines must stay refrigerated from factory to patient. Where reliable electricity is hard to come by, that chain of fridges is what stands between a working medicine and the person who needs it.
Drying a medicine is one way around it, and a common sugar called trehalose can protect it while it dries. But a clinic can be hot and humid for months. In that air the sugar can turn into crystals and push out the very thing it was protecting.
The question is not whether we can dry a medicine. It is whether we can make it survive the journey.
SCHEMATIC — NOT DATA. Illustrates the two published storage outcomes described above. No Wyrd Bio results exist yet.
Dried bacteriophage (a virus that infects bacteria) kept at room temperature for a few months.
How much better natural tardigrade proteins protected an enzyme than trehalose, in published work.
Published work uses the natural proteins or small tweaks to them. Nobody has built one from first principles.
Tardigrades, microscopic animals, can dry out almost completely and come back to life. Part of the trick is a family of proteins that, as water leaves, set into a glass-like shell around everything fragile. The cargo is held still, not kept wet.
Those natural proteins have already protected enzymes and a clotting-factor medicine better than sugar. But evolution shaped them for a tardigrade, not for a vaccine in a humid clinic. So we design the protector instead of borrowing it, building to the physical principle, then testing it where current methods actually break.
The tun is the desiccated form. Metabolism stops; CAHS proteins vitrify around what must be preserved. Our work takes the physics of that inner state and leaves the animal behind.
Before we build the company on this idea, we need evidence it works. Our first milestone is a proof-of-concept of about 10–12 weeks, designed so that even a failure would teach us something.
Use computers to propose protective proteins, narrow them down, and pick the best few to make for real.
Have bacteria produce those proteins, alongside the natural tardigrade protein and plain sugar as comparisons.
Dry a test molecule with each protector, store it hot and humid, and measure how much still works. Every option is tested side by side.
Design · weeks 1–2 / Build · weeks 3–6 / Stress-test · weeks 7–12 (approximate)
We started in June 2026 with the idea and the groundwork to test it, and we now have funding. The next thing the company needs is a lab partner.
We are early, and we would rather be clear about what we know and what we don’t. Here is the case as it stands today.
Broken cold chains keep medicines from reaching people, and the common sugar-based fix can fail in heat and humidity.
Published work relies on natural tardigrade proteins or small tweaks to them. We have not found anyone who has designed one from scratch.
One experiment of about 10–12 weeks tells us whether the idea works, before anyone commits more.
Backed by 1517 Fund, a Silicon Valley venture fund, plus a clear plan and honest comparisons against what people use today.
We have no results yet, and we are not offering investments on this page. If you would like to follow along or talk, we’d be glad to hear from you.
Our first experiments are designed and funded. We are looking for a wet lab that can host them, and for people who want to help build this company, or who think it will not work.
You have a lab with a plate reader and some bench space, and could host our first experiments.
Offer lab space →You work on stabilisation, protein design or global health, and want to help build this or partner with us.
Say hello →You think the approach has a hole in it. That is exactly the feedback we want.
Tell us why →hello@wyrd.bio